A.CardinD.Wang-GillamA.HuiL.et al (2017)
doi: 10.3389/fneur.2023.1103604 Received 20 November 2022 Accepted 02 January 2023 Published 26 January 2023 Volume 14 - 2023 Edited by Hui Lu, Zhejiang University, China Reviewed by Gang Zhao, Soochow University, China
Its a pleasant side effect
Phase 2 dose-finding trial (Lancet 2021) showed clear dose-response from 0.3 mg up to 4.5 mg/week, but 2.4 mg is the dose Novo Nordisk advanced into Phase 3 and is the most commonly self-reported community ceiling
"Everyone has days where they don't feel great in their body, but the difference is whether those thoughts begin controlling your life," Dow says
Once released from your gut, GLP-1 tells your brain you're full, slows down digestion, and manages insulin release